课题基金 / 基金详情

PHARMACOKINETICS OF LIQUID IBUPROFEN IN CHILDREN WITH CYSTIC FIBROSIS

PHARMACOKINETICS OF LIQUID IBUPROFEN IN CHILDREN WITH CYSTIC FIBROSIS
液体布洛芬在囊性纤维化儿童中的药代动力学
批准号:
6280849
负责人:
GERD CROPP
金额:
$2.39万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-12-01 至 1998-11-30

项目摘要

项目成果

GERD CROPP的其他基金

相似基金

相关文献

中文摘要
翻译
假设用高剂量的- 剂量布洛芬,抗炎药,将导致减少 肺中的炎症,如通过降低的特异性 支气管肺泡灌洗(BAL)中存在的炎症标志物和介质 液
英文摘要
The hypothesis is that treating children with cystic fibrosis with high- dose ibuprofen, anti-inflammatory drug, will result in reduced inflammation in the lung as reflected by lowered levels of specific inflammatory markers and mediators present in bronchoalveolar lavage (BAL) fluid.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PK OF LIQUID IBUPROFEN IN INFANTS, TODDLERS AND PRESCHOOLERS W/ CYSTIC FIBROSIS
PK OF LIQUID IBUPROFEN IN INFANTS, TODDLERS AND PRESCHOOLERS W/ CYSTIC FIBROSIS
PHARMACOKINETICS OF LIQUID IBUPROFEN IN CHILDREN WITH CYSTIC FIBROSIS
PK OF LIQUID IBUPROFEN IN INFANTS, TODDLERS AND PRESCHOOLERS W/ CYSTIC FIBROSIS
海外基金